Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions

Human Molecular Genetics

Volumn 24, Issue 25, 2015, Pages 7406-7420

  Qian, David C ^a   Byun, Jinyoung ^a   Han, Younghun ^a   Greene, Casey S ^b   Field, John K ^c   Hung, Rayjean J ^d   Brhane, Yonathan ^d   Mclaughlin, John R ^e   Fehringer, Gordon ^d   Landi, Maria Teresa ^f   Rosenberger, Albert ^g   Bickeböller, Heike ^g   Malhotra, Jyoti ^h   Risch, Angela ⁱ   Heinrich, Joachim ^j   Hunter, David J ^k   Henderson, Brian E ^l   Haiman, Christopher A ^l   Schumacher, Fredrick R ^l   Eeles, Rosalind A ^m   Easton, Douglas F ⁿ   Seminara, Daniela ^f   Amos, Christopher I ^a   more..

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j INSTITUTE OF EPIDEMIOLOGY   (Germany)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^m INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; NERVE GROWTH FACTOR; PROTEIN BAD;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL HYPOXIA; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY; BREAST TUMOR; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LUNG TUMOR; PROCEDURES; PROSTATE TUMOR;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 84959187584     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv440     Document Type: Article

References (142)

1. International Agency for Research on Cancer (2012) GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012.
2. American Cancer Society (2014) Cancer Facts & Figures 2014.
3. Figueiredo, J.C., Stram, D.O. and Haiman, C.A. (2014) The impact of GWAS findings on cancer etiology and prevention. Curr. Epidemiol. Rep., 1, 130-137.
4. Chung, C.C., Magalhaes, W.C., Gonzalez-Bosquet, J. and Chanock, S.J. (2010) Genome-wide association studies in cancer-current and future directions. Carcinogenesis, 31, 111-120.
5. Wang, K., Li, M. and Hakonarson, H. (2010) Analysing biological pathways in genome-wide association studies. Nat. Rev. Genet., 11, 843-854.
6. Stadler, Z.K., Thom, P., Robson, M.E., Weitzel, J.N., Kauff, N. D., Hurley, K.E., Devlin, V., Gold, B., Klein, R.J. and Offit, K. (2010) Genome-wide association studies of cancer. J. Clin. Oncol., 28, 4255-4267.
7. Wang, Y., McKay, J.D., Rafnar, T., Wang, Z., Timofeeva, M.N., Broderick, P., Zong, X., Laplana, M., Wei, Y., Han, Y. et al. (2014) Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat. Genet., 46, 736-741.
8. Siddiq, A., Couch, F.J., Chen, G.K., Lindstrom, S., Eccles, D., Millikan, R.C., Michailidou, K., Stram, D.O., Beckmann, L., Rhie, S. K. et al. (2012) A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum. Mol. Genet., 21, 5373-5384.
9. Amin Al Olama, A., Kote-Jarai, Z., Schumacher, F.R., Wiklund, F., Berndt, S.I., Benlloch, S., Giles, G.G., Severi, G., Neal, D.E., Hamdy, F.C. et al. (2013) A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum. Mol. Genet., 22, 408-415.
10. Greene, C.S., Krishnan, A., Wong, A.K., Ricciotti, E., Zelaya, R. A., Himmelstein, D.S., Zhang, R., Hartmann, B.M., Zaslavsky, E., Sealfon, S.C. et al. (2015) Understanding multicellular function and disease with human tissue-specific networks. Nat. Genet., 47, 569-576.
11. Conde, L., Bracci, P.M., Richardson, R., Montgomery, S.B. and Skibola, C.F. (2013) IntegratingGWAS and expression data for functional characterization of disease-associated SNPs: an application to follicular lymphoma. Am. J. Hum. Genet., 92, 126-130.
12. Lundby, A., Rossin, E.J., Steffensen, A.B., Acha, M.R., Newton-Cheh, C., Pfeufer, A. and Lynch, S.N., QT Interval International GWAS Consortium, Olesen, S.P., Brunak, S. et al. (2014) Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics. Nat. Methods, 11, 868-874.
13. Jia, P. and Zhao, Z. (2014) Network-assisted analysis to prioritize GWAS results: principles, methods and perspectives. Hum. Genet., 133, 125-138.
14. Menashe, I., Maeder, D., Garcia-Closas, M., Figueroa, J.D., Bhattacharjee, S., Rotunno, M., Kraft, P., Hunter, D.J., Chanock, S.J., Rosenberg, P.S. et al. (2010) Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res., 70, 4453-4459.
15. Eleftherohorinou, H., Hoggart, C.J., Wright, V.J., Levin, M. and Coin, L.J. (2011) Pathway-driven gene stability selection of two rheumatoid arthritis GWAS identifies and validates new susceptibility genes in receptor mediated signalling pathways. Hum. Mol. Genet., 20, 3494-3506.
16. Askland, K., Read, C. and Moore, J. (2009) Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum. Genet., 125, 63-79.
17. Mooney, M.A. and Wilmot, B. (2015) Gene set analysis: a step-by-step guide. Am. J. Med. Genet., 168, 517-527.
18. Zhong, H., Yang, X., Kaplan, L.M., Molony, C. and Schadt, E.E. (2010) Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am. J. Hum. Genet., 86, 581-591.
19. Schadt, E.E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum, P. Y., Kasarskis, A., Zhang, B., Wang, S., Suver, C. et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol., 6, e107.
20. Makinen, V.P., Civelek, M., Meng, Q., Zhang, B., Zhu, J., Levian, C., Huan, T., Segre, A.V., Ghosh, S., Vivar, J. et al. (2014) Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet., 10, e1004502.
21. Zhang, B., Gaiteri, C., Bodea, L.G., Wang, Z., McElwee, J., Podtelezhnikov, A.A., Zhang, C., Xie, T., Tran, L., Dobrin, R. et al. (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell, 153, 707-720.
22. Bunyavanich, S., Schadt, E.E., Himes, B.E., Lasky-Su, J., Qiu, W., Lazarus, R., Ziniti, J.P., Cohain, A., Linderman, M., Torgerson, D.G. et al. (2014) Integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism analysis identifies novel pathway in allergic rhinitis. BMC Med. Genomics, 7, 48.
23. Parkes, M., Cortes, A., van Heel, D.A. and Brown, M.A. (2013) Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet., 14, 661-673.
24. Pedroso, I., Lourdusamy, A., Rietschel, M., Nothen, M.M., Cichon, S., McGuffin, P., Al-Chalabi, A., Barnes, M.R. and Breen, G. (2012) Common genetic variants and gene-expression changes associated with bipolar disorder are overrepresented in brain signaling pathway genes. Biol. Psychiatry, 72, 311-317.
25. Jia, P., Wang, L., Fanous, A.H., Pato, C.N. and Edwards, T.L., International Schizophrenia Consortium and Zhao, Z. (2012) Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLoS Comput. Biol., 8, e1002587.
26. Raj, T., Shulman, J.M., Keenan, B.T., Chibnik, L.B., Evans, D. A., Bennett, D.A., Stranger, B.E. and De Jager, P.L. (2012) Alzheimer disease susceptibility loci: evidence for a protein network under natural selection. Am. J. Hum. Genet., 90, 720-726.
27. Detera-Wadleigh, S.D. and Akula, N. (2011) A systems approach to the biology of mood disorders through network analysis of candidate genes. Pharmacopsychiatry, 44, S35-S42.
28. Baranzini, S.E., Srinivasan, R., Khankhanian, P., Okuda, D.T., Nelson, S.J., Matthews, P.M., Hauser, S.L., Oksenberg, J.R. and Pelletier, D. (2010) Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain, 133, 2603-2611.
29. Rossin, E.J., Lage, K., Raychaudhuri, S., Xavier, R.J., Tatar, D. and Benita, Y., International Inflammatory Bowel Disease Genetics Consortium, Cotsapas, C. and Daly, M.J. (2011) Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet., 7, e1001273.
30. Cotsapas, C., Voight, B.F., Rossin, E., Lage, K., Neale, B.M., Wallace, C., Abecasis, G.R., Barrett, J.C., Behrens, T., Cho, J. et al. (2011) Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet., 7, e1002254.
31. Menon, R. and Farina, C. (2011) Shared molecular and functional frameworks among five complex human disorders: a comparative study on interactomes linked to susceptibility genes. PLoS One, 6, e18660.
32. Mooney, M.A., Nigg, J.T., McWeeney, S.K. and Wilmot, B. (2014) Functional and genomic context in pathway analysis of GWAS data. Trends Genet., 30, 390-400.
33. de Las Heras, J.I., Meinke, P., Batrakou, D.G., Srsen, V., Zuleger, N., Kerr, A.R. and Schirmer, E.C. (2013) Tissue specificity in the nuclear envelope supports its functional complexity. Nucleus, 4, 460-477.
34. Liu, M., King, V. and Lim, W.K. (2013) Assembling cell context-specific gene sets: a case in cardiomyopathy. J. Integr. Bioinform., 10, 234.
35. Lee, Y.H., Kim, J.H. and Song, G.G. (2014) Genome-wide pathway analysis of breast cancer. Tumour Biol., 35, 7699-7705.
36. Fehringer, G., Liu, G., Briollais, L., Brennan, P., Amos, C.I., Spitz, M.R., Bickeboller, H., Wichmann, H.E., Risch, A. and Hung, R.J. (2012) Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS One, 7, e31816.
37. Lee, D., Lee, G.K., Yoon, K.A. and Lee, J.S. (2013) Pathwaybased analysis using genome-wide association data from a Korean non-small cell lung cancer study. PLoS One, 8, e65396.
38. Jia, P., Liu, Y. and Zhao, Z. (2012) Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer. BMC Syst. Biol., 6, S13.
39. Ge, Y.Z., Xu, Z., Xu, L.W., Yu, P., Zhao, Y., Xin, H., Wu, R., Tan, S.J., Song, Q., Wu, J.P. et al. (2014) Pathway analysis of genome-wide association study on serum prostate-specific antigen levels. Gene, 551, 86-91.
40. Martin, A.M. and Weber, B.L. (2000) Genetic and hormonal risk factors in breast cancer. J. Natl. Cancer Inst., 92, 1126-1135.
41. Edwards, S.L., Beesley, J., French, J.D. and Dunning, A.M. (2013) BeyondGWASs: illuminating the dark road from association to function. Am. J. Hum. Genet., 93, 779-797.
42. Li, Y., Agarwal, P. and Rajagopalan, D. (2008) A global pathway crosstalk network. Bioinformatics, 24, 1442-1447.
43. Yang, J., Ferreira, T., Morris, A.P., Medland, S.E., Genetic Investigation of ANthropometric Traits (GIANT) Consortium, DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Madden, P.A.F., Heath, A.C., Martin, N.G., Montgomery, G.W. et al. (2012) Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet., 44, 369-375.
44. Veyrieras, J.B., Kudaravalli, S., Kim, S.Y., Dermitzakis, E.T., Gilad, Y., Stephens, M. and Pritchard, J.K. (2008) High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet., 4, e1000214.
45. Barshir, R., Basha, O., Eluk, A., Smoly, I.Y., Lan, A. and Yeger-Lotem, E. (2013) The TissueNet database of human tissue protein-protein interactions. Nucleic Acids Res., 41, D841-D844.
46. Croft, D., Mundo, A.F., Haw, R., Milacic, M., Weiser, J., Wu, G., Caudy, M., Garapati, P., Gillespie, M., Kamdar, M.R. et al. (2014) The Reactome pathway knowledgebase. Nucleic Acids Res., 42, D472-D477.
47. Benjamini, Y. and Yekutieli, D. (2001) The control of the false discovery rate in multiple testing under dependency. Ann. Stat., 29, 1165-1188.
48. Fadhal, E., Gamieldien, J. and Mwambene, E.C. (2014) Protein interaction networks as metric spaces: a novel perspective on distribution of hubs. BMC Syst. Biol., 8, 6.
49. Holmans, P., Green, E.K., Pahwa, J.S., Ferreira, M.A., Purcell, S.M. and Sklar, P., WellcomeTrust Case-ControlConsortium, Owen, M.J., O'Donovan, M.C. and Craddock, N. (2009) Gene ontology analysis ofGWAstudy data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet., 85, 13-24.
50. Ramanan, V.K., Shen, L., Moore, J.H. and Saykin, A.J. (2012) Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends Genet., 28, 323-332.
51. Cheng, L., Alexander, R.E., Maclennan, G.T., Cummings, O. W., Montironi, R., Lopez-Beltran, A., Cramer, H.M., Davidson, D.D. and Zhang, S. (2012) Molecular pathology of lung cancer: key to personalized medicine. Mod. Pathol., 25, 347-369.
52. Pao, W. and Girard, N. (2011) New driver mutations in nonsmall-cell lung cancer. Lancet Oncol., 12, 175-180.
53. Guedj, M., Marisa, L., de Reynies, A., Orsetti, B., Schiappa, R., Bibeau, F., MacGrogan, G., Lerebours, F., Finetti, P., Longy, M. et al. (2012) A refined molecular taxonomy of breast cancer. Oncogene, 31, 1196-1206.
54. Eroles, P., Bosch, A., Perez-Fidalgo, J.A. and Lluch, A. (2012) Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat. Rev., 38, 698-707.
55. da Silva, H.B., Amaral, E.P., Nolasco, E.L., de Victo, N.C., Atique, R., Jank, C.C., Anschau, V., Zerbini, L.F. and Correa, R.G. (2013) Dissecting major signaling pathways throughout the development of prostate cancer. Prostate Cancer, 2013, 920612.
56. Molloy, N.H., Read, D.E. and Gorman, A.M. (2011) Nerve growth factor in cancer cell death and survival. Cancers, 3, 510-530.
57. Polivka, J. Jr. and Janku, F. (2014) Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol. Ther., 142, 164-175.
58. Gordon, M.D. and Nusse, R. (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem., 281, 22429-22433.
59. Nasarre, P., Potiron, V., Drabkin, H. and Roche, J. (2014) Guidance molecules in lung cancer. Cell Adh. Migr., 4, 130-145.
60. Lachej, N., Didžiapetriene˙, J., Kazbariene, B., Kanopiene, D. and Jonusiene, V. (2012) Association between Notch signaling pathway and cancer. Acta Medica Lithuanica, 19, 427-437.
61. Ouyang, L., Shi, Z., Zhao, S., Wang, F.T., Zhou, T.T., Liu, B. and Bao, J.K. (2012) Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif., 45, 487-498.
62. Ciocca, D.R. and Calderwood, S.K. (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones, 10, 86-103.
63. Lennon, F.E., Moss, J. and Singleton, P.A. (2012) The mu-opioid receptor in cancer progression: is there a direct effect? Anesthesiology, 116, 940-945.
64. Wang, M. and Kaufman, R.J. (2014) The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat. Rev. Cancer, 14, 581-597.
65. Barabasi, A.L., Gulbahce, N. and Loscalzo, J. (2011) Network medicine: a network-based approach to human disease. Nat. Rev. Genet., 12, 56-68.
66. Compagno, M., Lim, W.K., Grunn, A., Nandula, S.V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A. et al. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature, 459, 717-721.
67. Lenz, G., Wright, G., Dave, S.S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J. et al. (2008) Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med., 359, 2313-2323.
68. Bettens, K., Sleegers, K. and Van Broeckhoven, C. (2013) Genetic insights in Alzheimer's disease. Lancet Neurol., 12, 92-104.
69. Lippitz, B.E. (2013) Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol., 14, e218-e228.
70. Mocellin, S., Marincola, F.M. and Young, H.A. (2005) Interleukin-10 and the immune response against cancer: a counterpoint. J. Leukoc. Biol., 78, 1043-1051.
71. Walser, T., Cui, X., Yanagawa, J., Lee, J.M., Heinrich, E., Lee, G., Sharma, S. and Dubinett, S.M. (2008) Smoking and lung cancer: the role of inflammation. Proc. Am. Thorac. Soc., 5, 811-815.
72. Caramori, G., Adcock, I.M., Casolari, P., Ito, K., Jazrawi, E., Tsaprouni, L., Villetti, G., Civelli, M., Carnini, C., Chung, K. F. et al. (2011) Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax, 66, 521-527.
73. Yan, D., Avtanski, D., Saxena, N.K. and Sharma, D. (2012) Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires beta-catenin activation via Akt/GSK3-and MTA1/Wnt1 protein-dependent pathways. J. Biol. Chem., 287, 8598-8612.
74. Battle, M., Gillespie, C., Quarshie, A., Lanier, V., Harmon, T., Wilson, K., Torroella-Kouri, M. and Gonzalez-Perez, R.R. (2014) Obesity induced a leptin-Notch signaling axis in breast cancer. Int. J. Cancer, 134, 1605-1616.
75. Mitrugno, A., Williams, D., Kerrigan, S.W. and Moran, N. (2014) A novel and essential role for FcgammaRIIa in cancer cell-induced platelet activation. Blood, 123, 249-260.
76. Gao, L., Smith, R.S., Chen, L.M., Chai, K.X., Chao, L. and Chao, J. (2010) Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway. Biol. Chem., 391, 803-812.
77. Choe, K.S., Cowan, J.E., Chan, J.M., Carroll, P.R., D'Amico, A.V. and Liauw, S.L. (2012) Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J. Clin. Oncol., 30, 3540-3544.
78. Xu, L.L., Sun, C., Petrovics, G., Makarem, M., Furusato, B., Zhang, W., Sesterhenn, I.A., McLeod, D.G., Sun, L., Moul, J. W. et al. (2006) Quantitative expression profile of PSGR in prostate cancer. Prostate Cancer Prostatic Dis., 9, 56-61.
79. Weng, J., Wang, J., Cai, Y., Stafford, L.J., Mitchell, D., Ittmann, M. and Liu, M. (2005) Increased expression of prostatespecific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers. Int. J. Cancer, 113, 811-818.
80. Rodriguez, M., Siwko, S., Zeng, L., Li, J., Yi, Z. and Liu, M. (2015) Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression. Oncogene (epub ahead of print).
81. Wang, M., Liu, F., Hsing, A.W., Wang, X., Shao, Q., Qi, J., Ye, Y., Wang, Z., Chen, H., Gao, X. et al. (2012) Replication and cumulative effects ofGWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium. Carcinogenesis, 33, 356-360.
82. Claussnitzer, M., Dankel, S.N., Kim, K.H., Quon, G., Meuleman, W., Haugen, C., Glunk, V., Sousa, I.S., Beaudry, J.L., Puviindran, V. et al. (2015) FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N. Engl. J. Med., 373, 895-907.
83. Shungin, D., Winkler, T.W., Croteau-Chonka, D.C., Ferreira, T., Locke, A.E., Magi, R., Strawbridge, R.J., Pers, T.H., Fischer, K., Justice, A.E. et al. (2015) New genetic loci link adipose and insulin biology to body fat distribution. Nature, 518, 187-196.
84. Ribeiro, R., Lopes, C. and Medeiros, R. (2006) The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis., 9, 19-24.
85. Malli, F., Papaioannou, A.I., Gourgoulianis, K.I. and Daniil, Z. (2010) The role of leptin in the respiratory system: an overview. Respir. Res., 11, 152.
86. Vansaun, M.N. (2013) Molecular pathways: adiponectin and leptin signaling in cancer. Clin. Cancer Res., 19, 1926-1932.
87. Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D.C., Fullam, A., Alexandrov, L.B., Tubio, J.M. et al. (2015) High burden and pervasive positive selection of somatic mutations in normal human skin. Science, 348, 880-886.
88. Risbridger, G.P., Davis, I.D., Birrell, S.N. and Tilley, W.D. (2010) Breast and prostate cancer: more similar than different. Nat. Rev. Cancer, 10, 205-212.
89. Grover, P.L. and Martin, F.L. (2002) The initiation of breast and prostate cancer. Carcinogenesis, 23, 1095-1102.
90. The GTEx Consortium (2015) The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science, 348, 648-660.
91. The GTEx Consortium (2013) The Genotype-Tissue Expression (GTEx) project. Nat. Genet., 45, 580-585.
92. Gajewski, T.F., Schreiber, H. and Fu, Y.X. (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol., 14, 1014-1022.
93. Mao, Y., Keller, E.T., Garfield, D.H., Shen, K. and Wang, J. (2013) Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev., 32, 303-315.
94. Heinrich, E.L., Walser, T.C., Krysan, K., Liclican, E.L., Grant, J. L., Rodriguez, N.L. and Dubinett, S.M. (2012) The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenviron., 5, 5-18.
95. Amos, C.I., Wu, X., Broderick, P., Gorlov, I.P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J. et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet., 40, 616-622.
96. Wang, Y., Broderick, P., Webb, E., Wu, X., Vijayakrishnan, J., Matakidou, A., Qureshi, M., Dong, Q., Gu, X., Chen, W.V. et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet., 40, 1407-1409.
97. Eisen, T., Matakidou, A. and Houlston, R. and Gelcaps Consortium (2008) Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS). BMC Cancer, 8, 244.
98. Power, C. and Elliott, J. (2006) Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol., 35, 34-41.
99. Hung, R.J., McKay, J.D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P. et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-637.
100. Scelo, G., Constantinescu, V., Csiki, I., Zaridze, D., Szeszenia-Dabrowska, N., Rudnai, P., Lissowska, J., Fabianova, E., Cassidy, A., Slamova, A. et al. (2004) Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (Europe). Cancer Causes Control, 15, 445-452.
101. Landi, M.T., Consonni, D., Rotunno, M., Bergen, A.W., Goldstein, A.M., Lubin, J.H., Goldin, L., Alavanja, M., Morgan, G., Subar, A.F. et al. (2008) Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative populationbased case-control study of lung cancer. BMC Public Health, 8, 203.
102. Hayes, R.B., Sigurdson, A., Moore, L., Peters, U., Huang, W.Y., Pinsky, P., Reding, D., Gelmann, E.P., Rothman, N., Pfeiffer, R. M. et al. (2005) Methods for etiologic and early marker investigations in the PLCO trial. Mutat. Res., 592, 147-154.
103. Sauter, W., Rosenberger, A., Beckmann, L., Kropp, S., Mittelstrass, K., Timofeeva, M., Wolke, G., Steinwachs, A., Scheiner, D., Meese, E. et al. (2008) Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol. Biomarkers Prev., 17, 1127-1135.
104. Dite, G.S., Jenkins, M.A., Southey, M.C., Hocking, J.S., Giles, G. G., McCredie, M.R., Venter, D.J. and Hopper, J.L. (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J. Natl. Cancer Inst., 95, 448-457.
105. Schmidt, M.K., Tollenaar, R.A., de Kemp, S.R., Broeks, A., Cornelisse, C.J., Smit, V.T., Peterse, J.L., van Leeuwen, F.E. and Van't Veer, L.J. (2007) Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J. Clin. Oncol., 25, 64-69.
106. Fagerholm, R., Hofstetter, B., Tommiska, J., Aaltonen, K., Vrtel, R., Syrjakoski, K., Kallioniemi, A., Kilpivaara, O., Mannermaa, A., Kosma, V.M. et al. (2008) NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat. Genet., 40, 844-853.
107. Fletcher, O., Johnson, N., Palles, C., dos Santos Silva, I., McCormack, V., Whittaker, J., Ashworth, A. and Peto, J. (2006) Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. J. Natl. Cancer Inst., 98, 1014-1018.
108. Frank, B., Hemminki, K., Wappenschmidt, B., Meindl, A., Klaes, R., Schmutzler, R.K., Bugert, P., Untch, M., Bartram, C.R. and Burwinkel, B. (2006) Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis, 27, 606-609.
109. Turnbull, C., Ahmed, S., Morrison, J., Pernet, D., Renwick, A., Maranian, M., Seal, S., Ghoussaini, M., Hines, S., Healey, C.S. et al. (2010) Genome-wide association study identifies five newbreast cancer susceptibility loci. Nat. Genet., 42, 504-507.
110. Li, J., Humphreys, K., Heikkinen, T., Aittomaki, K., Blomqvist, C., Pharoah, P.D., Dunning, A.M., Ahmed, S., Hooning, M.J., Martens, J.W. et al. (2011) A combined analysis of genomewide association studies in breast cancer. Breast Cancer Res. Treat., 126, 717-727.
111. Flesch-Janys, D., Slanger, T., Mutschelknauss, E., Kropp, S., Obi, N., Vettorazzi, E., Braendle, W., Bastert, G., Hentschel, S., Berger, J. et al. (2008) Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int. J. Cancer, 123, 933-941.
112. Calle, E.E., Rodriguez, C., Jacobs, E.J., Almon, M.L., Chao, A., McCullough, M.L., Feigelson, H.S. and Thun, M.J. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer, 94, 500-511.
113. Riboli, E., Hunt, K.J., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondiere, U.R., Hemon, B., Casagrande, C., Vignat, J. et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr., 5, 1113-1124.
114. Kolonel, L.N., Henderson, B.E., Hankin, J.H., Nomura, A.M., Wilkens, L.R., Pike, M.C., Stram, D.O., Monroe, K.R., Earle, M.E. and Nagamine, F.S. (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am. J. Epidemiol., 151, 346-357.
115. Colditz, G.A. and Hankinson, S.E. (2005) The Nurses' Health Study: lifestyle and health among women. Nat. Rev. Cancer, 5, 388-396.
116. Garcia-Closas, M., Brinton, L.A., Lissowska, J., Chatterjee, N., Peplonska, B., Anderson, W.F., Szeszenia-Dabrowska, N., Bardin-Mikolajczak, A., Zatonski, W., Blair, A. et al. (2006) Established breast cancer risk factors by clinically important tumour characteristics. Br. J. Cancer, 95, 123-129.
117. Hayes, R.B., Reding, D., Kopp, W., Subar, A.F., Bhat, N., Rothman, N., Caporaso, N., Ziegler, R.G., Johnson, C.C., Weissfeld, J.L. et al. (2000) Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control. Clin. Trials, 21, 349S-355S.
118. Antoniou, A.C., Wang, X., Fredericksen, Z.S., McGuffog, L., Tarrell, R., Sinilnikova, O.M., Healey, S., Morrison, J., Kartsonaki, C., Lesnick, T. et al. (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat. Genet., 42, 885-892.
119. Haiman, C.A., Chen, G.K., Vachon, C.M., Canzian, F., Dunning, A., Millikan, R.C., Wang, X., Ademuyiwa, F., Ahmed, S., Ambrosone, C.B. et al. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptornegative breast cancer. Nat. Genet., 43, 1210-1214.
120. Stevens, K.N., Vachon, C.M., Lee, A.M., Slager, S., Lesnick, T., Olswold, C., Fasching, P.A., Miron, P., Eccles, D., Carpenter, J. E. et al. (2011) Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res., 71, 6240-6249.
121. John, E.M., Hopper, J.L., Beck, J.C., Knight, J.A., Neuhausen, S. L., Senie, R.T., Ziogas, A., Andrulis, I.L., Anton-Culver, H., Boyd, N. et al. (2004) The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res., 6, R375-R389.
122. Schumacher, F.R., Berndt, S.I., Siddiq, A., Jacobs, K.B., Wang, Z., Lindstrom, S., Stevens, V.L., Chen, C., Mondul, A.M., Travis, R.C. et al. (2011) Genome-wide association study identifies new prostate cancer susceptibility loci. Hum. Mol. Genet., 20, 3867-3875.
123. Eeles, R.A., Kote-Jarai, Z., Giles, G.G., Olama, A.A., Guy, M., Jugurnauth, S.K., Mulholland, S., Leongamornlert, D.A., Edwards, S.M., Morrison, J. et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet., 40, 316-321.
124. Eeles, R.A., Kote-Jarai, Z., Al Olama, A.A., Giles, G.G., Guy, M., Severi, G., Muir, K., Hopper, J.L., Henderson, B.E., Haiman, C. A. et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet., 41, 1116-1121.
125. Andriole, G.L., Crawford, E.D., Grubb, R.L. III, Buys, S.S., Chia, D., Church, T.R., Fouad, M.N., Gelmann, E.P., Kvale, P.A., Reding, D.J. et al. (2009) Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med., 360, 1310-1319.
126. Duggan, D., Zheng, S.L., Knowlton, M., Benitez, D., Dimitrov, L., Wiklund, F., Robbins, C., Isaacs, S.D., Cheng, Y., Li, G. et al. (2007) Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J. Natl. Cancer Inst., 99, 1836-1844.
127. Hunter, D.J., Kraft, P., Jacobs, K.B., Cox, D.G., Yeager, M., Hankinson, S.E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A. et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
128. Yeager, M., Orr, N., Hayes, R.B., Jacobs, K.B., Kraft, P., Wacholder, S., Minichiello, M.J., Fearnhead, P., Yu, K., Chatterjee, N. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649.
129. Chatr-Aryamontri, A., Breitkreutz, B.J., Oughtred, R., Boucher, L., Heinicke, S., Chen, D., Stark, C., Breitkreutz, A., Kolas, N., O'Donnell, L. et al. (2015) The BioGRID interaction database: 2015 update. Nucleic Acids Res., 43, D470-D478.
130. Salwinski, L., Miller, C.S., Smith, A.J., Pettit, F.K., Bowie, J.U. and Eisenberg, D. (2004) The Database of Interacting Proteins: 2004 update. Nucleic Acids Res., 32, D449-D451.
131. Kerrien, S., Aranda, B., Breuza, L., Bridge, A., Broackes-Carter, F., Chen, C., Duesbury, M., Dumousseau, M., Feuermann, M., Hinz, U. et al. (2012) The IntAct molecular interaction database in 2012. Nucleic Acids Res., 40, D841-D846.
132. Licata, L., Briganti, L., Peluso, D., Perfetto, L., Iannuccelli, M., Galeota, E., Sacco, F., Palma, A., Nardozza, A.P., Santonico, E. et al. (2012) MINT, the molecular interaction database: 2012 update. Nucleic Acids Res., 40, D857-D861.
133. Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C.L., Haase, J., Janes, J., Huss, J.W. III et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol., 10, R130.
134. Berglund, L., Bjorling, E., Oksvold, P., Fagerberg, L., Asplund, A., Szigyarto, C.A., Persson, A., Ottosson, J., Wernerus, H., Nilsson, P. et al. (2008) A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol. Cell. Proteomics, 7, 2019-2027.
135. Petryszak, R., Burdett, T., Fiorelli, B., Fonseca, N.A., Gonzalez-Porta, M., Hastings, E., Huber, W., Jupp, S., Keays, M., Kryvych, N. et al. (2014) Expression Atlas update-a database of gene and transcript expression from microarray-and sequencing-based functional genomics experiments. Nucleic Acids Res., 42, D926-D932.
136. Yang, J., Lee, S.H., Goddard, M.E. and Visscher, P.M. (2011) GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet., 88, 76-82.
137. Delaneau, O. and Marchini, J., and The 1000 Genomes Project Consortium (2014) Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel. Nat. Commun., 5, 3934.
138. Delaneau, O., Marchini, J. and Zagury, J.F. (2012) A linear complexity phasing method for thousands of genomes. Nat. Methods, 9, 179-181.
139. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
140. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
141. Roshyara, N.R. and Scholz, M. (2014) fcGENE: a versatile tool for processing and transforming SNP datasets. PloS One, 9, e97589.
142. Fisher, R.A. (1925) Statistical Methods for ResearchWorkers. Oliver and Boyd, Edinburgh, UK.